Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Change in Cash (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Change in Cash for 14 consecutive years, with $690000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Change in Cash rose 2016.67% year-over-year to $690000.0, compared with a TTM value of $816000.0 through Jun 2025, up 250.21%, and an annual FY2023 reading of -$5.0 million, up 74.23% over the prior year.
  • Change in Cash was $690000.0 for Q2 2025 at SRx Health Solutions, up from -$1.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $30.7 million in Q3 2021 and bottomed at -$5.6 million in Q2 2022.
  • Average Change in Cash over 5 years is $37055.6, with a median of -$1.1 million recorded in 2023.
  • The sharpest move saw Change in Cash soared 2284.5% in 2021, then plummeted 1584.95% in 2022.
  • Year by year, Change in Cash stood at -$4.3 million in 2021, then grew by 27.25% to -$3.1 million in 2022, then surged by 120.85% to $655000.0 in 2023, then dropped by 7.63% to $605000.0 in 2024, then rose by 14.05% to $690000.0 in 2025.
  • Business Quant data shows Change in Cash for SRXH at $690000.0 in Q2 2025, -$1.9 million in Q1 2025, and $605000.0 in Q4 2024.